HomeDMP • FRA
add
Dermapharm Holding SE
Previous close
€31.20
Year range
€30.95 - €49.16
Market cap
1.69B EUR
Avg Volume
158.00
P/E ratio
26.93
Dividend yield
2.82%
Primary exchange
ETR
Market news
Financials
Income Statement
Revenue
Net income
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 274.14M | -7.17% |
Operating expense | 92.61M | 55.13% |
Net income | -2.69M | -109.01% |
Net profit margin | -0.98 | -109.68% |
Earnings per share | — | — |
EBITDA | 74.61M | -43.44% |
Effective tax rate | 178.11% | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 159.54M | 4.62% |
Total assets | 2.16B | 52.93% |
Total liabilities | 1.62B | 83.52% |
Total equity | 545.05M | — |
Shares outstanding | 53.84M | — |
Price to book | 3.12 | — |
Return on assets | 7.85% | — |
Return on capital | 10.38% | — |
Cash Flow
Net change in cash
(EUR) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -2.69M | -109.01% |
Cash from operations | 67.10M | -46.88% |
Cash from investing | 1.22M | 111.42% |
Cash from financing | -26.84M | 71.53% |
Net change in cash | 41.29M | 102.14% |
Free cash flow | 77.08M | -29.95% |
About
Dermapharm Holding SE or Dermapharm AG, based in Grünwald, is a publicly listed German pharmaceutical company specializing in the manufacture and distribution of dermatological and allergological preparations. Wikipedia
Founded
1991
Website
Employees
3,497